Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer

Published:2013-09 Issue:3 Volume:130 Page:426-430
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lowery William J.,Lowery Ashlei W.,Barnett Jason C.,Lopez-Acevedo Micael,Lee Paula S.,Secord Angeles Alvarez,Havrilesky Laura

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference37 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2012

2. Management strategies for recurrent platinum-resistant ovarian cancer;Naumann;Drugs,2011

3. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials;Blackledge;Br. J. Cancer,1989

4. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J. Clin. Oncol.,2001

5. Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study;Bruzzone;Oncology,2011

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Longer Life or a Quality Death? A Discrete Choice Experiment to Estimate the Relative Importance of Different Aspects of End-of-Life Care in the United Kingdom;MDM Policy & Practice;2024-01

2. Epithelial Ovarian Cancer;Tata Memorial Centre Textbook of Oncology;2024

3. Methodological challenges and potential solutions for economic evaluations of palliative and end-of-life care: A systematic review;Palliative Medicine;2023-12-23

4. Is Palliative Care Cost-Effective? A Systematic Review of the Literature;Home Health Care Management & Practice;2023-11-06

5. Effects of the Time of Hospice and Palliative Care Enrollment before Death on Morphine, Length of Stay, and Healthcare Expense in Patients with Cancer in Taiwan;Healthcare;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3